OBJECTIVE: To review retrospectively the experience of surgical treatment of @entity4924 in 108 @entity1 . METHODS: One hundred and eight @entity1 with @entity4924 underwent surgical correction, including tricuspid valve annuloplasty in 83 @entity1 (73.4%) and tricuspid valve replacement in 30 (5 with redo-operation). Concomitant procedure included division of the abnormal accessory conduction pathway in 8 @entity1 . RESULTS: The overall hospital mortality was 8.8%. The hospital mortality rate was 10.4% before 1990 and 5.5% after that time. There was a significant difference between the two periods (P < 0.05). The main causes of @entity204 were low cardiac output, @entity943 and @entity712 . The mean follow-up time was 6.3 years. The heart function improved to be NYHA class I or II in 92% of the @entity1 . CONCLUSIONS: Early surgical intervention is recommended for @entity1 with @entity4924 , especially for those with symptoms and @entity299 . Tricuspid valve repair should be performed if anterior leaflet of the tricuspid valve well developed. However, tricuspid valve replacement is advocated if anterior leaflet is @entity6349 or its origin displaced.

[Surgical treatment of XXXX : report of 108 cases].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity712 :: ('MESH:D006333', 'Disease') :: ['right heart failure'] @entity943 :: ('MESH:D001145', 'Disease') :: ['arrhythmias'] @entity299 :: ('MESH:D006331', 'Disease') :: ['cardiac enlargement'] @entity4924 :: ('MESH:D004437', 'Disease') :: ['Ebsteins malformation', "Ebstein's malformation"] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity6349 :: ('MESH:D004416', 'Disease') :: ['dysplastic']
@entity4924 :: (MESH:D004437,Disease) :: ['Ebstein's malformation']
